SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000905148-18-000657
Filing Date
2018-07-31
Accepted
2018-07-31 16:26:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc18-480_sc13da.htm SC 13D/A 121087
  Complete submission text file 0000905148-18-000657.txt   122546
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Subject) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89517 | Film No.: 18981445
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2000 MCKINNEY SUITE 2125 DALLAS TX 75201
Business Address 2000 MCKINNEY SUITE 2125 DALLAS TX 75201 214-871-6816
CPMG Inc (Filed by) CIK: 0001372218 (see all company filings)

IRS No.: 770616887 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A